Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
about
C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells.Chemical Compounds as Inhibitors of Kinase Activity for the Treatment of Cancer and COPD.mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potentialTargeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
P2860
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
@en
type
label
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
@en
prefLabel
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
@en
P2093
P2860
P1476
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer
@en
P2093
Brian Leyland-Jones
Bryant Dunetz
Corinne Ramos
David W Craig
Donald W Northfelt
Emanuel F Petricoin
Guido Gambara
Jessica Aldrich
John D Carpten
Joyce A O'Shaughnessy
P2860
P304
P356
10.1158/1078-0432.CCR-16-2656
P407
P50
P577
2017-04-26T00:00:00Z